Cargando…
Antimicrobial de-escalation in septic cancer patients: is it safe to back down?
Autores principales: | Paskovaty, Alla, Pastores, Stephen M., Gedrimaite, Zivile, Kostelecky, Natalie, Riedel, Elyn R., Seo, Susan K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582078/ https://www.ncbi.nlm.nih.gov/pubmed/26297120 http://dx.doi.org/10.1007/s00134-015-4016-6 |
Ejemplares similares
-
Gender, Race, and Ethnicity in Critical Care Fellowship Programs in the United States From 2016 to 2021
por: Pastores, Stephen M., et al.
Publicado: (2023) -
Graduates of a Multidisciplinary Critical Care Training Program from
2000 to 2020: Looking at Their First Job
por: Pastores, Stephen M., et al.
Publicado: (2022) -
434 Prevalence, Risk Factors, and Outcomes of Bacteremia Caused by Carbapenem-resistant Enterobacteriaceae in Neutropenic Patients with Hematologic Malignancies
por: Satlin, Michael J., et al.
Publicado: (2014) -
A Comprehensive Comparison of the Continual Reassessment Method to the Standard 3 + 3 Dose Escalation Scheme in Phase I Dose-Finding Studies
por: Iasonos, Alexia, et al.
Publicado: (2008) -
Potential impact of COVID-19 pandemic on escalating antimicrobial resistance in Pakistan
por: Rana, Muhammad Suleman, et al.
Publicado: (2021)